Abnormalities in Osteoclastogenesis and Decreased Tumorigenesis in Mice Deficient for Ovarian Cancer G Protein-Coupled Receptor 1 by Li, Hui et al.
Abnormalities in Osteoclastogenesis and Decreased
Tumorigenesis in Mice Deficient for Ovarian Cancer G
Protein-Coupled Receptor 1
Hui Li
1,2, Dongmei Wang
1, Lisam Shanjukumar Singh
1,2,3, Michael Berk
2, Haiyan Tan
2, Zhenwen Zhao
1,2,
Rosemary Steinmetz
1, Kashif Kirmani
1, Gang Wei
1, Yan Xu
1*
1Department of Obstetrics and Gynecology, Indiana University Cancer Center, Indiana University School of Medicine, Indianapolis, Indiana, United States of America,
2Department of Cancer Biology, Lerner Research Institute, Cleveland Clinic, Cleveland, Ohio, United States of America, 3Department of Biotechnology, Manipur
University, Canchipur, Manipur, India
Abstract
Ovarian cancer G protein-coupled receptor 1 (OGR1) has been shown to be a proton sensing receptor in vitro. We have
shown that OGR1 functions as a tumor metastasis suppressor gene when it is over-expressed in human prostate cancer cells
in vivo. To examine the physiological functions of OGR1, we generated conditional OGR1 deficient mice by homologous
recombination. OGR1 deficient mice were viable and upon gross-inspection appeared normal. Consistent with in vitro
studies showing that OGR1 is involved in osteoclastogenesis, reduced osteoclasts were detected in OGR1 deficient mice. A
pH-dependent osteoclasts survival effect was also observed. However, overall abnormality in the bones of these animals
was not observed. In addition, melanoma cell tumorigenesis was significantly inhibited in OGR1 deficient mice. OGR1
deficient mice in the mixed background produced significantly less peritoneal macrophages when stimulated with
thioglycolate. These macrophages also showed altered extracellular signal-regulated kinases (ERK) activation and nitric
oxide (NO) production in response to lipopolysaccharide. OGR1-dependent pH responses assessed by cAMP production and
cell survival in macrophages or brown fat cells were not observed, presumably due to the presence of other proton sensing
receptors in these cells. Our results indicate that OGR1’s role in osteoclastogenesis is not strong enough to affect overall
bone development and its role in tumorigenesis warrants further investigation. The mice generated can be potentially used
for several disease models, including cancers or osteoclast-related diseases.
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Introduction
We have previously cloned OGR1 from an ovarian cancer cell
line HEY [1]. Recently, we have shown OGR1 is a novel
metastasis suppressor gene for prostate cancer [2]. OGR1 and its
subfamily G protein-coupled receptors (GPCRs), GPR4, G2A and
T-cell death-associated gene 8 (TDAG8), have been shown to have
proton-sensing ability [3,4,5,6,7,8,9]. Many of these proton
sensing activities have been identified in cells over-expressing
one or more of these GPCRs. More recently, proton sensing
activities have been detected in cells from GPR4- and TDAG8-,
but not G2A-deficient mice [8,10,11].
Mice deficient in G2A, TDAG8, or GPR4 have been
generated. These knockout (KO) mice are viable and exhibit
different phenotypes. G2A KO mice demonstrate a normal
pattern of T and B cell lineage differentiation through young
adulthood. However, aged G2A-deficient animals (.1 year)
develop secondary lymphoid organ enlargement associated with
abnormal expansion of both T and B lymphocytes [12]. In
addition, other phenotypes related to bone marrow-derived cells,
including, monocytes/endothelial cells and macrophages, as well
as hepatic cells have been reported [8,13,14,15,16,17]. TDAG8 is
transcriptionally up-regulated by glucocorticoids (GCs) and
implicated by over-expression studies in psychosine-mediated
inhibition of cytokinesis [18,19]. Although TDAG8 expression
resembles the dynamic regulation described for known modula-
tors of GC-induced apoptosis during thymocyte development, it is
dispensable for psychosine-induced formation of multinucleated
cells. In addition, thymocytes in TDAG8 KO mice show normal
apoptosis following in vivo and in vitro GC treatment [11].
Moreover, acidic extracellular pH does not differentially
modulate the susceptibility of TDAG8 wild type (WT) and KO
thymocytes to GC-induced apoptosis [11]. However, in thymo-
cytes and splenocytes explanted from receptor-deficient mice,
TDAG8, but not G2A, is found to be critical for pH-dependent
cAMP production [8]. While this manuscript was in preparation,
Mogi et al have shown that TDAG8, but not OGR1 is involved in
pH-induced inhibitory effect on tumor necrosis factor-alpha
(TNF-a) production in macrophages [20]. GPR4 is expressed in
most endothelial cells and mediates sphingosylphosphorylcholine
(SPC)-induced angiogenic activities (11). GPR4 deficiency leads to
partially penetrated vascular abnormalities during development
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ex vivo aortic ring assay [10].
OGR1 has been identified as a strongly up-regulated gene
during osteoclastogenesis in csf1
tl/csf1
tl rats (CSF-deficient rat)
treated with macrophage colony-stimulating factor (M-CSF or
CSF-1) and in receptor activator of nuclear factor k B ligand
(RANKL, or TRANCE, TNFSF11)-induced osteoclast differenti-
ation in vitro [21]. The potential functional involvement of OGR1
in osteoclastogenesis has been demonstrated using an anti-OGR1
antibody and by inhibiting OGR1 with small inhibitory RNA
(siRNA) [21]. Moreover, systemic acidosis has detrimental effects
on the skeleton and local acidosis is associated with bone
destruction in inflammatory and neoplastic diseases. Survival
and calcium signaling of osteoclasts are significantly enhanced by
acidification of the medium in an OGR1-depedent manner [22].
The functional involvement of OGR1 has mainly been examined
using either OGR1 antibody, or a nonspecific OGR1 antagonist
Cu
2+, or siRNAs against OGR1. Since all these reagents all
potentially can have off-target effects, a more specific system is
needed to assess the physiological roles of OGR1.
Mesenchymal stem cells (MSCs) and hematopoietic stem cells
from bone marrow are capable of differentiating into monocytes,
osteoclasts, osteoblasts, and adipocytes, among other cell pheno-
types. These cell types are important for many biological
functions. Under normal physiological conditions, the differenti-
ation processes are tightly controlled. Imbalanced differentiation
and/or activation processes lead to pathological conditions and
diseases.
Derived from blood monocytes, macrophages are relatively long
lived phagocytotic cells of mammalian tissues. Macrophages are
involved in a variety of processes including pathogen destruction,
inflammation, tissue repairing and remodeling. They have a highly
plastic phenotype and their functional polarization is determined
by cytokines and factors found within local microenvironments
[23]. One of the functions of macrophages is to provide a defense
mechanism against tumor cells. However, tumor-associated
macrophages (TAMs), which represent the major inflammatory
component of the stroma of many solid tumors, are associated with
tumor progression and metastasis [23].
Brown and white adipose tissues (BAT and WAT) are key
players in obesity and related with health problems, such as type-2
diabetes and cardiovascular diseases. BAT-dependent non-shiver-
ing thermogenesis significantly affects the body’s energy balance.
In addition to its energy storage function, the fat tissues also secrete
a number of hormones and cytokines, and are involved in the
control of body metabolism and energy balance at multiple sites
[24,25]. BAT is of particular importance in neonates, small
mammals (such as mice) in cold environments, and animals that
hibernate, because its major physiological function is to dissipate
stored energy as heat. In human infants BAT comprises up to 5%
of total body weight, which then diminishes with age to virtually
nonexistent levels by adulthood.
Throughout an animal’s life, bone tissue is in a constant state of
turnover as a result of the combination of sequential removal of
bone tissue by osteoclasts and new bone deposition by osteoblasts.
Osteoclasts are bone-resorbing multinuclear giant cells that are
derived from hematopoietic mononuclear precursor cells under
the control of both M-CSF and RANKL [21]. These cells aid in
absorbing and removing excess bone tissues in the remodeling of
growing bones, or damaged bone in the repair of fractures.
We have generated and characterized OGR1-deficient mice to
address several critical issues: 1) the physiological functions of
OGR1 in mice; 2) the role of OGR1 in osteoclastogenesis; 3) the
OGR1-dependent pH responsiveness using OGR1-deficient cells;
and 4) the functions of OGR1 in other bone biological processes
when mice are challenged by exogenous stimuli, such as tumor
cells. We have found that in consistence with published data,
OGR1 is likely to be involved in osteoclastogenesis. In our hands,
we observed reduced osteoclasts derived from bone marrow cells
of OGR1 deficient mice. A weak pH-dependent osteoclasts
survival effect was also observed. However, the overall bone
structures of the mice were not affected and a significant pH-
regulated and OGR1-dependent biological effect was not
generally evidenced in OGR1-expressing cells [including macro-
phages and brown adipose derived cells (BADCs)], suggesting a
redundant effect of other OGR1 subfamily GPCRs in vivo.I n
addition, the effect and involvement of host cell OGR1 in
tumorigenesis of melanoma cells is of great interest and warrants
further investigation. Two additional abnormalities related to
peritoneal macrophages and BAT were observed in a mouse
background-dependent manner, suggesting involvement of mod-
ifying genes in different mouse backgrounds.
Materials and Methods
Reagents
Sphingosylphosphorylcholine (SPC) and lysophosphatidylcho-
line (LPC) were from Aventi Polar Lipids (Birmingham, AL) or
Toronto Research Chemicals (Toronto, Canada). M-CSF and
RANKL were from Peprotech (Rocky Hill, NJ). Anti-FLAG M2,
H2O2, thioglycolate (TG), lipopolysacchride (LPS), Latex beads,
sodium nitrite, Griess reagent, tartrate-resistant acid phosphatase
(TRAP) staining reagents and Masson’s Trichrome staining
reagents were purchased from Sigma (St. Louis, MO). Anti-
phospho-ERK, anti-ERK, anti-phospho-p38, anti-p38 were from
Cell Signaling Technology (Beverly, MA). Goat anti-iNOS,
TRITC-anti-rabbit were from BD (San Jose, CA). Anti-F4/80,
anti-PCNA, rabbit anit-arginase and anti-cyclooxygenase-2
(COX-2) were from Santa Cruz (Santa Cruz, CA). Anti-CD31
was from RDI (Fitzgerald, Concord, USA). Citrate buffer,
universal horse serum, VECTOR NovaRED, and hematoxylin
QS were from VECTOR (Burlingame, CA).
Generation of OGR1 knockout (KO) mice
OGR1 targeting construct has been generated through a
contract with AnTeq Transgenic Mice (Australia). In brief, A
13.2 kb Bam HI genomic fragment containing OGR1 gene was
subcloned from a bacterial artificial chromosome (BAC) clone (a
kind gift from Dr. Owen Witte’s lab at UCLA) into a pBS (KS) II
vector (plasmid #182). The 59 homology region of the OGR1
locus was PCR-amplified using OGR1 primers #1 and #2 and
plasmid #182 as a template. Primer #2 created a new Nco1 site
at the beginning of OGR1 (changed the first codon from ATG to
CTC). The PCR fragment was subcloned into pCR2.1.TOPO
(Invitrogen) to give plasmid #183. Exon 1 of OGR1 was PCR-
amplified using primers #7 and #8, while primer #7 introduced
a Xba I site for further cloning steps. The PCR fragment was
subcloned into pCR2.1.TOPO to give plasmid #188. This
complete OGR1 sequence was confirmed by sequencing analyses.
A 6.2 kb genomic fragment of the 39 untranslated region of the
OGR1 locus was subcloned into plasmid #182 to give plasmid
#189. A 1.4 kb floxed–neo-cassette was then cloned into plasmid
#189 linearized with Stu I to give plasmid #208. Stu I cuts at the
59 end of the 39 Hind III OGR1 region. The 3xFLAG region
encoding three adjacent FLAG epitopes was PCR-amplified from
plasmid p3xFLAG CMV-19 using primers #3 and #4 and the
latter primer included an Xho I site for further cloning. The
353 bp PCR product was subcloned into pCR2.1.TOPO (plasmid
Disruption of Mouse OGR1 Gene
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further subcloned in pBS(KS) II to get plasmid #196. A 2.6 kb
Kpn-Nco I fragment (59 homoloy region) from plasmid #183 was
then subcloned into plasmid #196 in front of the 36FLAG region
(plasmid #199). The loxP site in the 59 region of exon 1 was
cloned using annealed primers #5 and #6 and ligated into
plasmid #199 at the Xho I and Xba I sites. This gave rise to
plasmid #204, which was sequenced to confirm the integrity of
the 3xFLAG-LoxP-exon 1 junction. A 1.8 kb Xba I-Sac I
fragment including OGR1 exon 1 and ‘39 untranslated region
from plasmid #188 was subcloned into plasmid #203 to generate
plasmid #209. A 7.7 kb Hind III fragment of plasmid #208
harboring the neo-cassette flanked by loxP sites and the 39 OGR1
homology region was subcloned into plasmid #209 to give the
OGR1 targeting vector #218. The functionality of LoxP sites
were confirmed in an E. coli strain BNN123 constitutively
expressing recombinant Cre. The sequences of the primers used
were:
#1: 59 GGT ACC GGA GGA CGT GAG CAA CAA CT
#2: 59 ATG TTC CCC ATG GTT GGG CCA GAA
#3: 59 TCC TAC TTG GCA GTA CAT CT
#4: 59 ATC TCG AGC TTG TAC TCG TCA TCC TTG
#5: 59 TCG AGA TAA CTT CGT ATA GCA TAC ATT
ATA CGA AGT TAT
#6: 59 CTA GAT AAC TTC GTA TAA TGT ATG CTA
TAC GAA GTT ATC
#7: 59TCT AGAGGGAAC ATC ACT ACA GAA AAC TC
#8: 59 AGG AAC TTG GCT AAG GAC
The OGR1 targeting constructs were injected into ES cells at
the Transgenic Mouse Core Facility at Case Western Research
University (Cleveland, OH). Chimeric mice with germ line FLAG-
tagged OGR1 genes flanked by two loxP sites were generated.
Through breeding to C57/BL6 mice, these mice were used to
generate heterozygous mice with one copy of FLAG-tagged
OGR1. Subsequent breeding of heterozygous OGR1
fl/+ mice
generated homozygous OGR1
fl/fl mice. All offsprings from the
breeding of heterozygous OGR1
fl/+ mice were genotyped by DNA
analysis of tail clips. Initially both Southern blot and PCR analyses
were conducted to confirm genotype. Subsequent genotyping was
mainly conducted using PCR analyses. Homozygous mice with
OGR1 floxed (OGR1
fl/fl ) were bred to germ line Cre mice Zp-3
(a transgenic mouse line for the inactivation of loxP-flanked target
genes specifically in the female germ line [26]; Jackson Labs, Bar
Harbor, Maine). In addition, they were bred to Prm (Protamine-
Cre, a transgenic mouse line for the inactivation of loxP-flanked
target genes specifically in the male germ line of mice [27]; kindly
supplied by Dr. Guangbin Luo, Case Western Reserve University)
to generate OGR1
+/2Cre mice, which were bred further to
generate OGR1
2/2 (KO or deficient) mice. The OGR1
fl/fl mice
were designated OGR1 FL. OGR1
2/2 mice in the mixed
background have been backcrossed to C57/BL6 for 10 genera-
tions, the OGR1
+/+ 10
th generation mice were designated OGR1
wild type (OGR1 WT).
Phenotype analyses
OGR1 KO mice were viable and fertile. A complete mouse
phenotype analysis was conducted in two pairs of OGR1 KO and
FL mice (8 weeks old, one male and one female in each group) at
the Mouse Phenotypes Shared Resource, OHIO State University,
Columbus, OH. For determining the adiposity index, a previously
published method was used [28].
Tissue distribution assays
Organs were excised from mice and fixed in Zinc (BD, Franklin
Lakes, NJ) for 12–24 hr, then kept in 70% ethanol prior to being
embedded in paraffin and then sectioned at 5 mm. Post
deparaffinization and rehydration, the slides were treated with
citrate buffer for 20 min and with H2O2 (0.3%) in ethanol for
15 min. Universal horse serum was used to block the tissue
followed by anti-FLAG antibody (1:200 dilutions) treatment.
VECTOR NovaRED was used as the substrate and hematoxylin
QS as a counter stain.
RNA isolation, reverse transcription-PCR (RT-PCR)
Tissues were excised from mice and pulverized after snap freezing
in liquid nitrogen. Total RNA was extracted using RNeasy mini kit
(Qiangen, Maryland) and reverse transcribed by M-MLV (Invitro-
gen, Carlsbad, CA). Derived cDNAs were amplified using PCR
master mix (Promega, Madison, WI). Primer sequences for OGR1
wereasfollows: 59-CTCAATGACCTCCTTGTGATTG-39and59-
CTACCAGAAAACTCCTCACTATC-39. b-actin was amplified as
a housekeeping gene with primers 59-ACCGCTCGTTGCCAT-
TAGTGATGA -39 and 59-AAGGCCAACCGTGAAAAGAT-
GACC-39.
Brown adipose tissue isolation and proliferation of brown
adipose derived cells (BADCs)
Brown fat was dissected from the dorsal aspect of the thorax
between the scapulae, and formalin (10%) fixed & then paraffin
embedded, followed by H & E staining. To culture BADCs, brown
fat was cut into small pieces and placed into same volume of
collagenase solution (DMEM, 1% penicillin/streptomycin, 1%
BSA, 1 mg/mL collagenase type I, filtered). This suspension was
placed in a 37uC shaker at 200 rpm for 60 min. Following this,
DMEM medium (10 mL) containing 10% FBS, 1% penicillin/
streptomycin, 2% glutamine, 1% non essential amino acids and 1/
1000 b-mercaptoethanol was added to the brown fat cells. After
centrifugation at 2,000 rpm for 5 min, the white layer was
removed and the cell pellets were resuspended into 10 mL culture
medium, and filtered through a cell strainer. The cells were then
transferred to cell culture dishes and allowed to reach confluence.
For the proliferation/survival assays, cells were starved for 24 hr,
then treated with different stimulus for 24 and 48 hr [3]. 10 mLo f
3-(4,5-Dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide
(MTT, 5 mg/mL) was added into the cells 3 hr before harvesting.
The absorbance of the solution at 550 nm was determined using a
Vector
3 spectrophotometer (PerkinElmer, Waltham, MA).
Macrophage and osteoclast generation and
characterization
For peritoneal macrophages, mice were injected i.p. with 1 mL
of TG (4%). Macrophages were collected four days after injection.
Cells were harvested by peritoneal washings using RPMI. After
washing, the cells were cultured in RPMI with 10% FBS for 2 hr.
The non-adherent cells were removed and over 80% of the
adherent cells were macrophages [29]. Bone marrow derived
macrophages (BMMs) were obtained from the femurs of 6–10-
week-old mice [30]. In brief, the ends of the bones were cut off,
and the marrow was flushed from amputated femurs using a 1 mL
syringe to obtain a suspension, which was then passed through a
27-gauge needle for dispersion. Marrow cell suspensions (500 mL;
1610
6 cells) were plated in low M-CSF [3% L 929 cell-
conditioned medium (L-CM) as a source of M-CSF] in RPMI
containing 20% FBS. L-CM was produced by seeding 2.5610
5
cells in a 175-cm
2 tissue culture flask with 50 mL of basic medium
Disruption of Mouse OGR1 Gene
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filtered through a 0.2-mm filter, and frozen in aliquots at 280uC.
After allowing stroma cells to adhere overnight, non-adherent cells
were collected and plated in high M-CSF (30% L-CM). After three
days, the medium was removed along with non-attached cells, and
new medium containing 30% L-CM was added. Adherent
macrophages were homogeneous populations after 7 days of
culture. The cells were stained with Diff-quick and counted. To
differentiate macrophages into osteoclasts, fresh medium with
RANKL (50 ng/mL) was added on the third day and scored three
days later by counting TRAP-positive cells.
Phagocytosis and nitric oxide (NO) production assays
Peritoneal macrophages (1610
4 cells/300 mL) were incubated
in 48-well plates and treated with latex beads (1610
6) for 3 hr.
The assays were terminated by washing cells with ice-cold PBS.
The cells were then fixed in methanol for 30 min. Phagocytosis
was quantified under a fluorescent microscope by counting the
number of internalized beads in at least 200 cells, which was
recorded as phagocytotic index by the formula: 1006(cell number
with one bead+3.56cell number with 2–5 beads+86cell number
with 6–10 beads+206cell number with over 10 beads) /total cell
numbers. For NO production, peritoneal macrophages (5610
5)i n
100 mL of RPMI containing 10% FBS were cultured in 96-well
plate for 2 hr at 37uC. Cells were treated by replacing with
medium (0.5% FBS in 100 mL) and LPS (50 mLo f1mg/mL) for
18 hr. The levels of NO in the supernatant were assayed by
mixing the same volume of supernatants (100 mL) and Griess
reagent in a new 96- well plate. The plates were incubated for
15 min at room temperature and read at 570 nm using a plate
reader. The concentration of nitrite in the culture supernatant was
calculated from a standard curve generated from diluting sodium
nitrite in water at a concentration range of 0.01–100 mM.
Prostaglandin production and COX-2 expression
95% confluent cells in 24-well plates were treated with different
pH buffers for 9 hr or 25 hr [31,32]. The supernatants were
collected for prostaglandin analysis using HPLC-mass spectrom-
etry (API-4000, Applied Biosystems). In brief, prostaglandins were
extracted from cell supernatants (500 mL in each sample) in the
presence of 14:0 lysophosphatidic acid (LPA, 10 pmol) as an
internal standard using chloroform (2 mL), methanol (2 mL), and
HCl (6 N, 10 mL). The ions with the m/z at 351 (the parent ion)
and 271 (the daughter ion) were used for identification of
prostaglandins. A TARGA C18 5 mM, 2.1 mm ID610 mm TR-
0121-C185 (Higgins Analytical, Southborough, MA USA) HPLC
column was used, and the mobile phase was MeOH/water/
NH4OH (90:10:0.1, v/v/v), 6 min/sample. The cell pellets were
collected for analyzing COX-2 expression.
Western blot analyses
Macrophages (10
6) cultured in 6-well plate were rinsed with
PBS and stimulated by LPS (100 ng/mL), SPC or LPC (2.5 mM)
for 30 min. Cells were lysed in 100 mL of laemmli sample buffer
(BIO-RAD, Hercules, CA), extract were resolved on a 10% SDS-
polyacrylamide gel and transferred to polyvinylidene difluoride
membrane. Membranes were blocked in 5% skim milk for 2 hr
and then incubated with indicated primary antibodies overnight at
4uC. After incubation with corresponding secondary antibodies for
1 hr at room temperature, membranes were developed using an
ECL plus western blotting detection system (GE Healthcare,
Buckinghamshire UK). Protein loading was verified by stripping
and reprobing the blots with antibodies against b-actin.
Cyclic AMP (cAMP) production and cell survival at
different pH
Peritoneal macrophages were plated in 24-well plates, treated
with different pH buffers containing the phosphodiesterase
inhibitor isobutylmethylxanthine (IBMX, 1mM) for 30 min, and
then lysed with 0.1 M HCl (60 mL). Cell lysates were used for the
cAMP assay according to the kit instructions (Cyclic AMP EIA
Kit, from Cayman, Cat # 581001). For the survival assays,
macrophages or bone marrow-derived osteoclasts were plated in
96-well plates for 2 hr at 37uC with 5% CO2 and then cultured in
medium at different pHs at 37uC with 0% CO2 for 20 hr.
Bone histomorphometrical and immunohistochemical
analyses
Bone samples from 8-week-old animals were fixed in Bouin’s
solution overnight, decalcified in EDTA (14%) for 12 days, and
embedded in paraffin. Sections were then stained with Masson’s
Trichrome Stain Kit for morphological observation.
Melanoma tumorigenesis
B16-F10 cells were cultured in RPMI with 10% FBS. 1610
7
and 5610
5 cells in 100 mL of PBS were subcutaneously injected
into flanks of the mixed background and the pure C57/BL6
background mice, respectively. The mice were sacrificed when
they appeared moribund (9–14 days post-injection). The animal
research complied with all relevant federal guidelines and policies
of the Laboratory Animal Resource Center at Indiana University
School of Medicine.
Statistical analyses
All data in this study was expressed as mean6SD of three or
more independent experiments in triplicate. Differences between
treatment groups were analyzed using Student’s t test and two-
tailed distribution in Microsoft excel.
Results
Generation of OGR1 deficient mice and OGR1 expression
in tissues
To study the physiological role of OGR1, we have established
an OGR1 deficient mouse strain. Generation of OGR1 deficient
mice was described in detail in the Materials and Methods. The
overall strategy for constructing the OGR1 targeting vector was
shown in Figure 1A. The results from OGR1 genotyping were
shown in Figure 1B. OGR1 was expressed in the lung, testis, heart,
brain, spleen, thymus, brown fat, small intestine, colon, peripheral
blood leukocytes (PBL), macrophages, stomach, ovary, and white
fat, but not in the liver, kidney, and skeletal muscle of the OGR1
FL mice, as detected by RT-PCR. OGR1 expression in the
prostate was weak, but detectable (Figure 2A). The complete lack
of OGR1 expression in OGR1 KO mice was confirmed in all
tissues examined. We inserted a three-FLAG tag in front of OGR1
in the knock-in construct so that the endogenous OGR1
expression at the protein level can be detected in tissues using
anti-FLAG M2 antibody. Immunohistochemical staining of the
lung of OGR1 FL mice showed that OGR1 was expressed in the
cuboidal/columar epithelial cells covering the large airways of the
lung and in the vascular smooth muscle cells surrounding a large
blood vessel (Figure 2B). This tissue expression pattern of OGR1
was similar to that observed in human tissues as demonstrated
previously [1,33].
Disruption of Mouse OGR1 Gene
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brown adipose tissue (BAT) abnormality in the mixed
background
OGR1 KO mice were viable and fertile. A complete mouse
phenotype analysis was conducted in two pairs of OGR1 KO and
OGR1 FL mice (8 weeks old, one male and one female in each
group). Body weights did not differ substantially among the mice
examined. In these two pairs of mice, the spleens of OGR1 KO
mice appeared to be somewhat smaller than those of the FL mice,
whereas the livers and hearts of the KO mice were somewhat
larger than those of the FL mice. However, additional analysis in
more mice did not demonstrate statistical differences in these
organ weights (data not shown). Histological analyses in FL and
KO did not reveal significant differences in the majority of tissues,
and representative data are shown in Figure 3.
The initial analyses also revealed that the intrascapular BAT
deposit was heavier in the KO (0.35 and 0.28 g) than the FL (0.10
and 0.11 g) mice, which may be related to altered adiposity in the
KO mice. Consistent differences in BAT weights and sizes were
observed in additional pairs of FL and KO mice (Figure 4A). H &
E staining showed that while the white fat tissues (WAT) from FL
and KO mice were similar, the BAT from KO mice were less
dense when compared to those from FL mice (Figure 4B), which
may be related, in part, to the enlarged size of BAT in OGR1 KO
mice.
OGR1 has been shown to have proton-sensing activity in
various cells [3,6,9,34]. In addition, SPC may modulate OGR1’s
actions [6,9]. SPC has been shown to induce proliferation of
human adipose tissue-derived mesenchymal stem cells via
activation of c-Jun N-terminal kinase (JNK) [35]. To test whether
BAT from FL and KO mice respond differentially to pH and/or
SPC, we isolated BADCs and tested the effects of SPC or pH
changes on cell proliferation. SPC (2.5 mM) modestly stimulated
cell proliferation at 24 hr and this effect was not significantly
different in BADCs from FL versus KO mice (Figure 5A). Acidic
pH induced lower levels of proliferation than the physiological pH
(7.4), and again no statistical difference was observed in BADCs
from FL vs. KO mice (Figure 5B). We have backcrossed OGR1
deficient mice into C57/BL6 background (10 generations). When
Figure 1. Generation of conditional OGR1 deficient mice. (A) Strategy for constructing the OGR1 targeting vector. (B) Genotyping was
performed to identify floxed (FL), 2/2 (KO) and +/+ (WT) mice.
doi:10.1371/journal.pone.0005705.g001
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background, no difference was observed (data not shown),
suggesting that the BAT abnormality is related to the mouse
background.
OGR1 deficiency reduced macrophage production in
mice of the mixed background
Microscopic examination of the tissues did not reveal obvious
genotype-related differences between KO and FL mice. Hemato-
logical tests, including packed cell volume (PCV), hemoglobin (g/
dL), red blood cells (RBC, 610
12), mean corpuscular or cell
volume (MCV, fL), mean corpuscular or cell hemoglobin
concentration (MCHC, g/dL), red cell distribution width
(RDW), RBC morphology, mean platelet volume (MPV),
nucleated cells (610
9/L), neutrophils (%), lymphocytes (%),
monocytes (%), eosinophils (%), basophils (%), leukocyte mor-
phology, and platelet count were not significantly different
between KO and FL mice (data not shown), except that the
Figure 2. OGR1 expression in mouse tissues and cells. (A) OGR1 expression in various tissues from FL and KO mice detected by RT-PCR. The
PCR program was 94uC, 2 min; 25 cycles for actin and 35 cycles for OGR1 (94uC, 30 s; 55uC, 1 min; 72uC, 1 min); 72uC, 10 min, except both actin and
OGR1 in macrophages were amplified by 30 cycles. BAT, brown adipose tissue; BM, bone marrow; PBL, peripheral blood leucocytes. The arrows
indicate DNA ladders with 500 bp. (B) OGR1 distribution in lung tissue from FL and C57/BL6 mice. Anti-FLAG M2 antibody (1:200) was used.
Representative positively stained cells are indicated by arrows. Scale bar=100 mm.
doi:10.1371/journal.pone.0005705.g002
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PLoS ONE | www.plosone.org 6 May 2009 | Volume 4 | Issue 5 | e5705Figure 3. Immunohistochemistry of FL and KO mice tissues. The representative H & E staining of the liver, kidney, testis, prostate, ovary and
uterus were presented. Scale bar=100 mm.
doi:10.1371/journal.pone.0005705.g003
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PLoS ONE | www.plosone.org 7 May 2009 | Volume 4 | Issue 5 | e5705Figure 4. Brown adipose tissue abnormality in OGR1 KO mice in the mixed background. (A) Brown adipose tissues in the KO mice were
larger than those in FL mice. (a) Weights of BAT (9 mice from FL and 9 mice from KO). (b) Representative appearance of BAT from FL and KO mice. (B)
H & E staining of BAT and WAT in FL and KO mice. * represents a P value of ,0.05, and *** represents a P value of ,0.001. Scale bar=100 mm.
doi:10.1371/journal.pone.0005705.g004
Figure 5. Proliferation of brown adipose tissue-derived cells in OGR1 KO mice in the mixed background. (A) SPC stimulated
proliferation was not significantly different in BAT from FL vs. KO mice. SPC (2.5 mM) or LPC (2.5 mM) was used. (B) The effect of pH on proliferation
was not significantly different in FL vs. KO. The results in this figure are representative of at least 3 independent experiments. * represents a P value of
,0.05.
doi:10.1371/journal.pone.0005705.g005
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PLoS ONE | www.plosone.org 8 May 2009 | Volume 4 | Issue 5 | e5705percentage of monocytes and neutrophils appear to be higher and
lower, respectively, in OGR1 deficient mice. We have repeated
blood cell counts in more pairs of mice and confirmed that the
percentage of monocytes in blood was higher in OGR1 KO mice
versus FL mice (Figure 6A). OGR1 was expressed in mouse
macrophages (Figure 2A). Interestingly, KO mice produced less
peritoneal macrophages in response to TG, when compared to the
FL mice (Figure 6B). However, when BMMs were counted after
treating bone marrow cells with M-CSF, no difference was
observed in KO and FL mice (Figure 6C), although OGR1 was
also expressed in bone marrow cells and PBL (Figure 2A). These
results suggest that the reduced peritoneal macrophages was not
related to deficiencies in bone marrow cells or macrophage
precursor cells in the blood, and it may be more specific to TG
and/or bacterium-induced process.
We further tested whether macrophages from KO mice have
altered phagocytotic activity. We found that the phagocytosis
indexes in FL and KO mice were 27.565.8 and 26.6 64.4,
respectively, which were not statistically different (more than 10
pairs of mice were tested). LPS-induced NO production in
macrophages is important for their biological function [36]. We
found that NO production stimulated by LPS was significantly
reduced in OGR1 KO mice compared to FL mice (Figure 6D).
LPS can also activate several signaling pathways, including ERK
and p38 MAP kinase pathways. While LPS-induced p38 activation
or LPC-induced ERK and p38 phosphorylation were not
significantly different, LPS-stimulated phosphorylation of ERK
was significantly reduced in macrophages from KO mice when
compared to that from FL mice (Figure 6E). To address the proton
sensing issue, we tested cAMP production and cell survival of
Figure 6. Reduction of TG-induced peritoneal macrophage numbers and NO production in OGR1 KO mice in the mixed
background. (A) The percentages of monocytes in peripheral blood were higher in KO than that in WT mice. Blood samples were obtained from
facial vein of FL and KO mice (n=6 in each group). (B) TG-stimulated peritoneal macrophage numbers in KO mice were reduced when compared to
those from WT mice (n=20 in each group). (C) Bone marrow-derived macrophage numbers in FL and KO mice after M-CSF stimulation (n=6 in each
group) were not significantly different. (D) Nitric Oxide production from KO peritoneal macrophages was reduced than that of WT macrophages.
Macrophages were stimulated with LPS (330 ng/mL) for 18 hr. (E) LPS-induced ERK activation was reduced in OGR1 KO macrophages. TG-induced
peritoneal macrophages were treated with LPS (100 mg/mL) (a), or LPC (2.5 mM) (b) for 30 min prior to sample collection for Western blot analyses. (F)
pH-modulated cAMP formation (a) or cell survival (b) was not significantly different in peritoneal macrophages from FL and KO mice. Cells were
treated with indicated pH buffer and IBMX (1 mM) for 30 min. Proton effect on the survival of macrophages were conducted for 20 hr. The results in
this figure are representative of at least 3 independent experiments. * represents a P value of ,0.05, and *** represents a P value of ,0.001.
doi:10.1371/journal.pone.0005705.g006
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indicated that there was no significant difference in these activities
at any of the pHs tested between FL and KO macrophages
(Figure 6F).
Similar to BAT abnormality, we found that TG-stimulated
peritoneal macrophage number were not significantly different in
mice in a pure C57/BL6 background, suggesting this is also a
mouse background-dependent phenotype.
The role of OGR1 in osteoclastogenesis
OGR1 has been implicated in osteoclastogenesis [21,22,37].
OGR1 deficient mice are the best system to test this concept under
physiological conditions. Gross abnormalities of KO mouse bones
were not observed as shown in the X-ray of bone from both FL
and KO mice (Figure 7), suggesting that even OGR1 might even
have a role in osteoclastogenesis, the overall effects are not
apparent and that a redundant role of other genes may be involved
in vivo. This is further supported by bone immunohistochemical
analyses using Masson’s Trichrome staining. The histomorphom-
etry showed that the bone volume/total volume, osteoblasts
number, osteoclasts number, trabecular thickness and bone-
marrow cavity were not significantly different between OGR1
KO and WT mice in either mixed background or pure C57/BL6
background (Figure 8).
To test osteoclastogenesis more specifically, isolated bone
marrow cells were induced to differentiate by M-CSF and
RANKL and the numbers of osteoclasts were counted. After
testing more than 20 pairs of mice, a consistent reduction in
osteoclast formation was observed in KO mice in both the mixed
and the pure C57/BL6 backgrounds (Figure 9A). Therefore, this is
a phenotype of OGR1 that was persistent in the C57/BL6
background. We also examined the survival of osteoclasts at
different pHs. While OGR1 FL mice had significantly reduced cell
survival at pH 6.8, when compared to survival at pH 7.4, the
OGR1 KO mice had a similar survival rate at pH 7.4 and 6.8
(Figure 9B). This was the only pH-dependent difference detected
in cells from FL and OGR1 KO mice in the mixed background,
which was also detected between cells from WT and OGR1 KO
mice in the C57/BL6 background.
It has been reported that in vitro OGR1 is involved in
prostaglandin production and activation of COX-2 in bone and
smooth muscle cells in response to pH changes [31,32]. We tested
these concepts in osteoclasts and macrophages. We found that
neither prostaglandin production from either osteoclasts
(Figure 9C, a and b) or macrophages (Figure 9D, a and b) nor
COX-2 expression in osteoclasts (Figure 9C, c) was differentially
regulated in FL and KO mice. This suggests that the effects
observed in vitro using overexpression systems may not completely
mimic in vivo physiological systems, and/or that other OGR1
subfamily genes, such as G2A, GPR4, and/or TDAG8 may play
similar and redundant roles in vivo.
OGR1 deficiency reduced tumorigenesis of melanoma
cells in both mixed and C57/BL6 backgrounds
Since macrophages play important roles in cancers, the
abnormalities in TG-stimulated macrophages prompted us to test
whether host cell OGR1 deficiency affects tumor development in
mice. We used melanoma B16-F10 cells, since these cells are
highly malignant and when used in relatively high numbers, they
form tumors even in non-syngenic mice. We found that the tumor
sizes were significantly smaller in OGR1 KO mice when
compared to WT mice in either the mixed (Figure 10A) or the
pure C57/BL6 background (Figure 10B). H & E staining and
CD31 staining showed that the tumors from KO mice had less
blood vessels and CD31-positive endothelial cells than those from
WT mice, suggesting reduced angiogenesis in tumors in KO mice.
In addition, less tumor-infiltrated F4/80-positive macrophages
were detected in tumors from KO mice (Figure 11), suggesting
that decreased TAMs may be also responsible for reduced
tumorigenesis.
Discussion
Limited proton-sensing activities were observed in cells
from OGR1-deficient mice
The proton sensing activities of the OGR1 subfamily of
GPCRs, including G2A, GPR4, and TDAG8 have been reported
previously (6, 8, 15, 18, 24, 32). Using gene knockout techniques,
mice deficient in G2A, GPR4, and TDAG8 have been previously
Figure 7. Role of OGR1 in osteoclastogenesis of the mixed and
the C57/BL6 background mice. Radiographs of WT (left) and KO
(right) mice (conducted in Mouse Phenotyping Shared Resource, Ohio
State University).
doi:10.1371/journal.pone.0005705.g007
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PLoS ONE | www.plosone.org 10 May 2009 | Volume 4 | Issue 5 | e5705Figure 8. Histology of femurs from FL and KO mice. Masson’s Trichrome staining of bones in male and female OGR1 FL and KO mice. Nuclei
were stained black, cytoplasm was red, muscle fibers were red, and collagen was blue. Scale bar=100 mm.
doi:10.1371/journal.pone.0005705.g008
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assays, pH-sensing activities have been detected in GPR4- and
TDAG8-, but not in G2A-deficient cells [8,10,20]. A common
scenario that has been revealed from these studies is that the pH-
dependent activities are highly cell type-, signaling pathway-, and
biological activity-specific. We have tested the pH-induced effects
in macrophages, osteoclasts, and BADCs, the three major cell
types where some alterations have been observed in the OGR1
KO mice. However, these studies showed that there was only a
very limited pH-induced cellular effect (osteoclast cell survival) was
observed. While this manuscript was in preparation, Mogi et al
have reported that TDAG8, but not OGR1 is involved in the pH
induced inhibitory effect on TNF-a production in macrophages
[20], which is consistent with our results. The most likely
explanation of these results is that other OGR1 subfamily GPCRs
are also expressed in these tested cells and they play certain
redundant roles in vivo. These questions can only be further
clarified when double, triple or even quadruple knockout mice are
generated. This subfamily of GPCRs may also be regulated or
modulated by a group of lysophospholipids (11, 25, 27, 36, 38).
Similar to the pH effects, we did not observed altered lipid effects
in WT verses KO cells, which can be interpreted as a redundant
effect or lack of lipid effect through OGR1 in these cells.
Taken together, OGR1 subfamily receptors mediate the effects
of and/or are regulated by extracellular pH changes and certain
lysophospholipids. These effects are highly cell type-, G protein-,
signaling pathway-specific. The systems used to detect these effects
are also highly relevant. In particular, the conclusions derived on
Figure9.Reduced osteoclasts differentiatedfrom bonemarrowcellsinOGR1 KOmice.(A)M-CSFandRANKL-inducedosteoclastnumbers in
OGR1 KOmice were reduced. (B)pH effects onsurvival of osteoclasts. Osteoclastswere culturedin mediumwith different pHfor20 hr. (C)Prostaglandin
production and COX-2 expression in osteoclasts. Osteoclasts were cultured in different pH buffer (300 mL) in 24-well plates for indicated times and the
supernatants were collected for prostaglandin analysis (a and b) and the cells were lysed for COX-2 expression analysis at 9 hr (c). The differences in
different groups are not statistically significant (P.0.05). (D) Prostaglandin production in macrophages. The results in this figure are representative of at
least 3 independent experiments. * represents a P value of ,0.05, ** represents a P value of ,0.005, and *** represents a P value of ,0.001.
doi:10.1371/journal.pone.0005705.g009
Disruption of Mouse OGR1 Gene
PLoS ONE | www.plosone.org 12 May 2009 | Volume 4 | Issue 5 | e5705the functions/signaling pathways of this family of GPCRs from in
vitro over-expression systems are not completely consistent with the
results obtained from knockout mice as described above,
emphasizing the importance to study the pathophysiological roles
of these receptors in vivo and the potential redundant functions
among OGR1 subfamily GPCRs.
The potential involvement of OGR1 in BAT and
macrophages were mouse genetic background-
dependent
We have found that the cell types affected by OGR1 in the
mixed or the C57/BL6 background are all potentially derived
from mesenchymal stem cells (MSCs) or hematopoietic stem cells
from bone marrow, which are capable of differentiating into
monocytes, osteoclasts, osteoblasts, and adipocytes, among other
cell phenotypes. We consistently found higher accumulations of
BAT both in terms of dimension and weight in OGR1 KO mice in
the mixed background. However, these differences disappeared
when mice were in the C57/BL6 background, suggesting that a
modifying gene(s) in different mouse background may play a role
in regulating BAT. To our knowledge, OGR1 is the first gene
showing an affect on the size of BAT in a mouse-background
dependent manner. The mechanisms by which OGR1 regulates
this phenotype and the identification of the modifying gene
warrant further studies. The extent of brown fat abnormality
observed in OGR1 KO mice did not clearly affected the mouse
Figure 10. Melanoma growth was suppressed in OGR1 KO mice in both mixed and C57/BL6 backgrounds. (A, a) Tumorigenesis of
melanoma cells was reduced in OGR1 KO mice in the mixed background. B16-F10 cells (10
7 mouse melanoma cells) were injected s.c into FL and KO
mice in the mixed background. Mice were sacrificed at 9–14 days post-injection. (b) Representative pictures of the tumors developed in FL and KO
mice in the mixed background. (B). Summary of tumor volumes (a) and weights (b) in mice with the C57/BL6 background (n=10 in WT and n=12 in
KO). Tumorigenesis of melanoma cells was reduced in OGR1 KO mice.
doi:10.1371/journal.pone.0005705.g010
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PLoS ONE | www.plosone.org 13 May 2009 | Volume 4 | Issue 5 | e5705Figure 11. Immunohistochemistry staining of melanoma tissue from WT and KO mice. H & E staining of tumor sections for gross
observation. Staining of tumor section with anti-CD31 (1:50) for angiogenesis analysis. Staining of tumor section with anti-F4/80 (1:75) to view
macrophage infiltration. Representative positively stained cells were indicated by arrows. Scale bar=100 mm.
doi:10.1371/journal.pone.0005705.g011
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conditions. It might be interesting to test whether under different
temperatures these mice behave differently from WT mice, since
brown fat is mainly involved in thermogenesis.
The role of OGR1 in macrophages may be related to its
function in tumorigenesis of melanoma cells, since reduced TAMs
were observed in tumors from KO mice, which also correlated
with reduced tumor sizes. However, similar to the BAT
phenotype, altered peritoneal macrophages were not consistently
observed in mice with a pure C57/BL6 background, suggesting
that a modifying gene(s) is likely to be involved.
OGR1 was likely to be involved in osteoclastogenesis and
tumorigenesis
The phenotypes of OGR1 KO mice related to osteoclast and
melanoma tumor formation were consistent in both mixed and
C57/BL6 backgrounds. Our results suggested that although
OGR1 may play a role in osteoclastogenesis, its effect on overall
bone physiology was rather minimal. It is possible that under
certain pathological conditions, the defect in osteoclast numbers
and/or their response to pH changes will affect some biological
functions. This is true when we test tumorigenesis when mice were
challenged with melanoma cells in either the mixed and or the
C57/BL6 background. The mechanisms by which host cells
OGR1 acts to regulate tumorigenesis remains to be further
investigated. Intriguingly, we have recently shown that OGR1
over-expression in tumor cells displays a tumor metastasis
suppressing role for prostate cancer [2]. It is highly interesting to
further study the apparent opposing roles of OGR1 in tumor vs.
host cells.
In summary, similar to other members of this family, OGR1
deficiency did not significantly affect overall mouse physiology.
While OGR1 deficiency did not result in a strong phenotype by
itself, it may generate interesting and strong phenotypes when
mice are challenged, as we report here for melanoma cells. In
addition, OGR1 and its subfamily GPCRs may have redundant
roles in vivo, which can be further revealed when more than one of
these genes is depleted. With this report, the initial phenotypic
analyses of the four members of OGR1-subfamily GPCRs has
now been completed and more interesting results are expected to
be generated from double to quadruple deficient mice.
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